Phenotypes and virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 clonal lineages

mSphere

Volumn 1, Issue 3, 2016, Pages

  King, Jessica M ^a   Kulhankova, Katarina ^a   Stach, Christopher S ^a,b   Vu, Bao G ^a   Salgado Pabón, Wilmara ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Infective endocarditis; Rabbit model; Sepsis; Staphylococcus aureus; Superantigens; Virulence factors

Indexed keywords

EID: 85033351829     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00071-16     Document Type: Article

References (52)

1. Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A. 2005. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 67: 1084-1092. http://dx.doi.org/10.1111/j.1523-1755.2005.00174.x
2. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. 2015. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28:603-661. http://dx.doi.org/10.1128/CMR.00134-14
3. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK, Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771. http://dx.doi.org/10.1001/jama.298.15.1763
4. Nienaber JJ, Sharma Kuinkel BK, Clarke-Pearson M, Lamlertthon S, Park L, Rude TH, Barriere S, Woods CW, Chu VH, Marín M, Bukovski S, Garcia P, Corey GR, Korman T, Doco-Lecompte T, Murdoch DR, Reller LB, Fowler VG, Jr, International Collaboration on Endocarditis-Microbiology Investigators. 2011. Methicillinsusceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J Infect Dis 204:704-713. http://dx.doi.org/10.1093/ infdis/jir389
5. Tristan A, Rasigade JP, Ruizendaal E, Laurent F, Bes M, Meugnier H, Lina G, Etienne J, Celard M, Tattevin P, Monecke S, Le Moing V, Vandenesch F, French AEPEI Study Group on Infective Endocarditis. 2012. Rise of CC398 lineage of Staphylococcus aureus among infective endocarditis isolates revealed by two consecutive population-based studies in France. PLoS One 7:e51172. http://dx.doi.org/10.1371/ journal.pone.0051172
6. Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, Lonsway D, Patel JB, Kuehnert MJ, Gorwitz R. 2008. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 46:2837-2841. http://dx.doi.org/10.1128/JCM.00480-08
7. Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK, Active Bacterial Core surveillance MRSA Investigators. 2009. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 47:1344-1351. http://dx.doi.org/10.1128/JCM.02264-08
8. Roberts JC. 2013. Community-associated methicillin-resistant epidemic clone USA100; more than a nosocomial pathogen. Springerplus 2:133. http://dx.doi.org/10.1186/2193-1801-2-133
9. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99:7687-7692. http:// dx.doi.org/10.1073/pnas.122108599
10. Stegger M, Driebe EM, Roe C, Lemmer D, Bowers JR, Engelthaler DM, Keim P, Andersen PS. 2013. Genome sequence of Staphylococcus aureus strain CA-347, a USA600 methicillin-resistant isolate. Genome Announc 1(4):e00517-13. http://dx.doi.org/10.1128/genomeA.00517-13
11. Sakoulas G, Guram K, Reyes K, Nizet V, Zervos M. 2014. Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting. J Clin Microbiol 52:2172-2174. http://dx.doi.org/10.1128/JCM.00189-14
12. Moore CL, Osaki-Kiyan P, Perri M, Donabedian S, Haque NZ, Chen A, Zervos MJ. 2010. USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit. J Clin Microbiol 48: 2307-2310. http://dx.doi.org/10.1128/JCM.00409-10
13. Brosnahan AJ, Schlievert PM. 2011. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J 278: 4649-4667. http://dx.doi.org/10.1111/j.1742-4658.2011.08151.x
14. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 48:707-710
15. Li V, Chui L, Simmonds K, Nguyen T, Golding GR, Yacoub W, Ferrato C, Louie M. 2014. Emergence of new CMRSA7/USA400 methicillinresistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012. J Clin Microbiol 52:2439-2446. http://dx.doi.org/10.1128/ JCM.00505-14
16. Rose HR, Holzman RS, Altman DR, Smyth DS, Wasserman GA, Kafer JM, Wible M, Mendes RE, Torres VJ, Shopsin B. 2015. Cytotoxic virulence predicts mortality in nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus. J Infect Dis 211:1862-1874. http://dx.doi.org/10.1093/infdis/jiu554
17. Hall TA, Sampath R, Blyn LB, Ranken R, Ivy C, Melton R, Matthews H, White N, Li F, Harpin V, Ecker DJ, McDougal LK, Limbago B, Ross T, Wolk DM, Wysocki V, Carroll KC. 2009. Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization-mass spectrometry. J Clin Microbiol 47:1733-1741. http://dx.doi.org/10.1128/JCM.02175-08
18. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW. 2010. Methicillinresistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15(41):pii=19688. http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId:19688
19. Chen L, Chavda KD, Solanki M, Mediavilla JR, Mathema B, Schlievert PM, Kreiswirth BN. 2013. Genetic variation among Panton-Valentine leukocidin-encoding bacteriophages in Staphylococcus aureus clonal complex 30 strains. J Clin Microbiol 51:914-919. http://dx.doi.org/ 10.1128/JCM.03015-12
20. Sharma-Kuinkel BK, Mongodin EF, Myers JR, Vore KL, Canfield GS, Fraser CM, Rude TH, Fowler VG, Jr, Gill SR. 2015. Potential influence of Staphylococcus aureus clonal complex 30 genotype and transcriptome on hematogenous infections. Open Forum Infect Dis 2:ofv093. http:// dx.doi.org/10.1093/ofid/ofv093
21. Jones MB, Montgomery CP, Boyle-Vavra S, Shatzkes K, Maybank R, Frank BC, Peterson SN, Daum RS. 2014. Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains. BMC Genomics 15:1145. http:// dx.doi.org/10.1186/1471-2164-15-1145
22. DeLeo FR, Kennedy AD, Chen L, Bubeck Wardenburg J, Kobayashi SD, Mathema B, Braughton KR, Whitney AR, Villaruz AE, Martens CA, Porcella SF, McGavin MJ, Otto M, Musser JM, Kreiswirth BN. 2011. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A 108:18091-18096. http://dx.doi.org/10.1073/pnas.1111084108
23. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282: 1123-1125
24. DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R. 2011. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One 6:e22997. http://dx.doi.org/10.1371/journal.pone.0022997
25. Fowler VG, Jr, Nelson CL, McIntyre LM, Kreiswirth BN, Monk A, Archer GL, Federspiel J, Naidich S, Remortel B, Rude T, Brown P, Reller LB, Corey GR, Gill SR. 2007. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J Infect Dis 196:738-747. http://dx.doi.org/10.1086/ 520088
26. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339: 520-532. http://dx.doi.org/10.1056/NEJM199808203390806
27. Jarraud S, Peyrat MA, Lim A, Tristan A, Bes M, Mougel C, Etienne J, Vandenesch F, Bonneville M, Lina G. 2001. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166:669-677. http://dx.doi.org/ 10.4049/jimmunol.166.1.669
28. Vu BG, Stach CS, Salgado-Pabón W, Diekema DJ, Gardner SE, Schlievert PM. 2014. Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. J Infect Dis 210:1920-1927. http:// dx.doi.org/10.1093/infdis/jiu350
29. Dinges MM, Orwin PM, Schlievert PM. 2000. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16-34. http://dx.doi.org/10.1128/ CMR.13.1.16-34.2000
30. Gouaux JE, Braha O, Hobaugh MR, Song L, Cheley S, Shustak C, Bayley H. 1994. Subunit stoichiometry of staphylococcal alphahemolysin in crystals and on membranes: a heptameric transmembrane pore. Proc Natl Acad Sci U S A 91:12828-12831. http://dx.doi.org/ 10.1073/pnas.91.26.12828
31. Doery HM, Magnusson BJ, Cheyne IM, Gulasekharam J. 1963. A phospholipase in staphylococcal toxin which hydrolyses sphingomyelin. Nature 198:1091-1092. http://dx.doi.org/10.1038/1981091a0
32. Doery HM, Magnusson BJ, Gulasekharam J, Pearson JE. 1965. The properties of phospholipase enzymes in staphylococcal toxins. J Gen Microbiol 40:283-296. http://dx.doi.org/10.1099/00221287-40-2-283
33. Spaulding AR, Satterwhite EA, Lin YC, Chuang-Smith ON, Frank KL, Merriman JA, Schaefers MM, Yarwood JM, Peterson ML, Schlievert PM. 2012. Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Front Cell Infect Microbiol 2:18. http://dx.doi.org/10.3389/fcimb.2012.00018
34. Klein E, Smith DL, Laxminarayan R. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13:1840-1846. http://dx.doi.org/10.3201/ eid1312.070629
35. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463-473. http://dx.doi.org/10.1001/archinternmed.2008.603
36. Fowler VG, Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS. 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012-3021. http://dx.doi.org/10.1001/jama.293.24.3012
37. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. 2013. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One 8:e60033. http://dx.doi.org/10.1371/journal.pone.0060033
38. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. 2006. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34:2588-2595. http:// dx.doi.org/10.1097/01.CCM.0000239121.09533.09
39. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317. http://dx.doi.org/10.1086/421946
40. Laabei M, Uhlemann AC, Lowy FD, Austin ED, Yokoyama M, Ouadi K, Feil E, Thorpe HA, Williams B, Perkins M, Peacock SJ, Clarke SR, Dordel J, Holden M, Votintseva AA, Bowden R, Crook DW, Young BC, Wilson DJ, Recker M, Massey RC. 2015. Evolutionary trade-offs underlie the multi-faceted virulence of Staphylococcus aureus. PLoS Biol 13:e1002229. http://dx.doi.org/10.1371/journal.pbio.1002229
41. Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. 2013. Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26:422-447. http://dx.doi.org/10.1128/ CMR.00104-12
42. Salgado-Pabón W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR, Peterson ML, Schlievert PM. 2013. Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. mBio 4:e00494-13. http://dx.doi.org/ 10.1128/mBio.00494-13
43. Salgado-Pabón W, Schlievert PM. 2014. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol 12: 585-591. http://dx.doi.org/10.1038/nrmicro3308
44. Musser JM, Schlievert PM, Chow AW, Ewan P, Kreiswirth BN, Rosdahl VT, Naidu AS, Witte W, Selander RK. 1990. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A 87:225-229. http://dx.doi.org/10.1073/ pnas.87.1.225
45. Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK, for the Active Bacterial Core surveillance (ABCs), MRSA Investigators of the Emerging Infections Program. 2012. Impact of USA300 methicillinresistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections. Clin Infect Dis 55:232-241. http://dx.doi.org/10.1093/cid/cis408
46. Pragman AA, Herron-Olson L, Case LC, Vetter SM, Henke EE, Kapur V, Schlievert PM. 2007. Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression. J Bacteriol 189:7515-7519. http://dx.doi.org/10.1128/ JB.00547-07
47. Salgado-Pabón W, Case-Cook LC, Schlievert PM. 2014. Molecular analysis of staphylococcal superantigens. Methods Mol Biol 1085: 169-185. http://dx.doi.org/10.1007/978-1-62703-664-1_10
48. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675. http://dx.doi.org/ 10.1038/nmeth.2089
49. Mootz JM, Malone CL, Shaw LN, Horswill AR. 2013. Staphopains modulate Staphylococcus aureus biofilm integrity. Infect Immun 81: 3227-3238. http://dx.doi.org/10.1128/IAI.00377-13
50. White MJ, Boyd JM, Horswill AR, Nauseef WM. 2014. Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils. Infect Immun 82:1559-1571. http://dx.doi.org/10.1128/IAI.01168-13
51. Salgado-Pabón W, Schlievert PM. 2016. Aortic valve damage for the study of left-sided, native valve infective endocarditis in rabbits. Methods Mol Biol 1396:73-80. http://dx.doi.org/10.1007/978-1-4939-3344-0_6
52. Salgado-Pabón W, Herrera A, Vu BG, Stach CS, Merriman JA, Spaulding AR, Schlievert PM. 2014. Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage. J Infect Dis 210:784-792. http://dx.doi.org/10.1093/infdis/jiu146